echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Zhou Jing's team revealed a new mechanobiological mechanism of venous graft restenosis after arterial-vein transplantation

    Zhou Jing's team revealed a new mechanobiological mechanism of venous graft restenosis after arterial-vein transplantation

    • Last Update: 2022-05-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Coronary artery bypass grafting (CABG) is the gold standard for the treatment of patients with complex multivessel and / or left main coronary artery disease [1] .


    Mitofusin 2 ( mitofusin 2, MFN2) is an inhibitory molecule of smooth muscle cell proliferation , which can function through mitochondria-dependent and mitochondria-independent regulatory pathways [6,7]


    This study found that after the venous graft was implanted in the arterial system, the high mechanical stretch caused by arterial hypertension acting on the venous wall could lead to the transcriptional repression of MFN2 by activating the ROCK/JNK/SP1 signaling pathway in smooth muscle cells ; the deletion of MFN2 On the one hand, by inhibiting the ubiquitination and degradation of PFK1 mediated by E3 ubiquitin ligase TRIM21 , the content of PFK1 and the level of cellular glycolysis can be increased; on the other hand, it can also directly inhibit mitochondrial oxidative phosphorylation .


    Zhou Jing's research group is devoted to studying the mechanism of the influence of hemodynamic factors (such as blood flow shear and mechanical stretch, matrix stiffness and topology, etc.


    Original link:

    https:// Caliskan E, De Souza DR, Boning A, Liakopoulos OJ, Choi YH, Pepper J, Gibson CM, Perrault LP, Wolf RK, Kim KB, Emmert M Y.


    [2] Sousa- Uva M, Neumann FJ, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Juni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini G G , Windecker S, Yadav R, Zembala MO, Group ESCS D.


    [3] Li Y, Liu S, Zhang Z, Xu Q, Xie F, Wang J, Ping S, Li C, Wang Z, Zhang M, Huang J, Chen D, Hu L, Li C.


    [4] Li F, Guo WY, Li WJ, Zhang DX, Lv AL, Luan RH, Liu B, Wang H C.


    [5] Wernig F, Mayr M, Xu Q.


    [6] Ryan J, Dasgupta A, Huston J, Chen KH, Archer S L.


    [7] Fang X, Chen X, Zhong G, Chen Q, Hu C.


    [8] Li T, Han J, Jia L, Hu X, Chen L, Wang Y.


    (Peking University School of Basic Medicine )

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.